Cargando…

The Metabolome-Wide Signature of Major Depressive Disorder

Major Depressive Disorder (MDD) is an often-chronic condition with substantial molecular alterations and pathway dysregulations involved. Single metabolite, pathway and targeted metabolomics platforms have indeed revealed several metabolic alterations in depression including energy metabolism, neuro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jansen, Rick, Milaneschi, Yuri, Schranner, Daniela, Kastenmuller, Gabi, Arnold, Matthias, Han, Xianlin, Dunlop, Boadie W, Rush, A John, Kaddurah-Daouk, Rima, Penninx, Brenda WJH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543022/ https://www.ncbi.nlm.nih.gov/pubmed/37790319 http://dx.doi.org/10.21203/rs.3.rs-3127544/v1

Ejemplares similares

Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients
por: Bhattacharyya, Sudeepa, et al.
Publicado: (2019)

Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment
por: Bhattacharyya, Sudeepa, et al.
Publicado: (2019)

Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids
por: MahmoudianDehkordi, Siamak, et al.
Publicado: (2022)

Metabolomic profiles discriminating anxiety from depression
por: de Kluiver, Hilde, et al.
Publicado: (2021)

Metabolomics signatures of depression: the role of symptom profiles
por: de Kluiver, Hilde, et al.
Publicado: (2023)

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy
por: Batra, Richa, et al.
Publicado: (2023)

The brain-derived neurotrophic factor pathway, life stress, and chronic multi-site musculoskeletal pain
por: Generaal, Ellen, et al.
Publicado: (2016)

Dissection of depression heterogeneity using proteomic clusters
por: van Haeringen, Marije, et al.
Publicado: (2023)

Metabolite Concentration Changes in Humans After a Bout of Exercise: a Systematic Review of Exercise Metabolomics Studies
por: Schranner, Daniela, et al.
Publicado: (2020)

Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
por: Penninx, Brenda WJH, et al.
Publicado: (2013)

Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature
por: Brydges, Christopher R., et al.
Publicado: (2021)

A role for vitamin D and omega-3 fatty acids in major depression? An exploration using genomics
por: Milaneschi, Yuri, et al.
Publicado: (2019)

An integrative study of five biological clocks in somatic and mental health
por: Jansen, Rick, et al.
Publicado: (2021)

Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression
por: Nho, Kwangsik, et al.
Publicado: (2021)

Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression
por: MahmoudianDehkordi, Siamak, et al.
Publicado: (2021)

Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease
por: Horgusluoglu, Emrin, et al.
Publicado: (2021)

Involvement of inflammatory gene expression pathways in depressed patients with hyperphagia
por: de Kluiver, Hilde, et al.
Publicado: (2019)

Metabolic Profiling of Patients with Schizophrenia
por: Kaddurah-Daouk, Rima
Publicado: (2006)

Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts
por: St. John-Williams, Lisa, et al.
Publicado: (2019)

Circulating lipid profiles are associated with cross-sectional and longitudinal changes of central biomarkers for Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2023)

Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
por: Han, Xianlin, et al.
Publicado: (2011)

Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
por: Varma, Vijay R., et al.
Publicado: (2018)

Peripheral serum metabolomic profiles inform central cognitive impairment
por: Wang, Jingye, et al.
Publicado: (2020)

Metabolomics enables precision medicine: “A White Paper, Community Perspective”
por: Beger, Richard D., et al.
Publicado: (2016)

Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder
por: Grant, Caroline W., et al.
Publicado: (2022)

Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants
por: Rotroff, D M, et al.
Publicado: (2016)

Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
por: St John-Williams, Lisa, et al.
Publicado: (2017)

Physiological extremes of the human blood metabolome: A metabolomics analysis of highly glycolytic, oxidative, and anabolic athletes
por: Schranner, Daniela, et al.
Publicado: (2021)

Neuroimaging-based biomarkers for treatment selection in major depressive disorder
por: Dunlop, Boadie W., et al.
Publicado: (2014)

Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
por: Borkowski, Kamil, et al.
Publicado: (2021)

Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data
por: Jo, Taeho, et al.
Publicado: (2023)

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
por: Nho, Kwangsik, et al.
Publicado: (2019)

Methylome-wide association findings for major depressive disorder overlap in blood and brain and replicate in independent brain samples
por: Aberg, Karolina A., et al.
Publicado: (2018)

Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
por: Beger, Richard D., et al.
Publicado: (2020)

Psychiatric symptoms and cognitive impairment in “Long COVID”: the relevance of immunopsychiatry
por: Penninx, Brenda W.J.H.
Publicado: (2021)

Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
por: Arnold, Matthias, et al.
Publicado: (2020)

Metabolomics dissection of depression heterogeneity and related cardiometabolic risk
por: Alshehri, Tahani, et al.
Publicado: (2023)

Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
por: Trupp, Miles, et al.
Publicado: (2012)

Performance of the Adult ADHD Self-Report Scale-v1.1 in Adults with Major Depressive Disorder
por: Dunlop, Boadie W., et al.
Publicado: (2018)

A characterization of postzygotic mutations identified in monozygotic twins
por: Ouwens, Klaasjan G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l5uqrg0n0s1seo73o71sbp5knr